SOPHiA GENETICS SA

NasdaqGS SOPH

SOPHiA GENETICS SA Market Capitalization on January 14, 2025: USD 224.56 M

SOPHiA GENETICS SA Market Capitalization is USD 224.56 M on January 14, 2025, a -24.73% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

SOPHiA GENETICS SA 52-week high Market Capitalization is USD 366.90 M on March 04, 2024, which is 63.39% above the current Market Capitalization.
SOPHiA GENETICS SA 52-week low Market Capitalization is USD 192.01 M on January 10, 2025, which is -14.50% below the current Market Capitalization.
SOPHiA GENETICS SA average Market Capitalization for the last 52 weeks is USD 276.59 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NasdaqGS: SOPH

SOPHiA GENETICS SA

CEO	Dr. Jurgi Camblong M.B.A., Ph.D.
IPO Date	July 23, 2021
Location	Switzerland
Headquarters	Rue du Centre 172
Employees	430
Sector	Technology
Industries Software-as-a-Service (SaaS) Telehealth

Description

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

Key trends

Past 5 years